Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study

Adelline Twimukye, Agnes Bwanika Naggirinya, Rosalind Parkes-Ratanshi, Ronnie Kasirye, Agnes Kiragga, Barbara Castelnuovo, Jacob Wasswa, Maria Sarah Nabaggala, Elly Katabira, Mohammed Lamorde, Rachel Lisa King, Adelline Twimukye, Agnes Bwanika Naggirinya, Rosalind Parkes-Ratanshi, Ronnie Kasirye, Agnes Kiragga, Barbara Castelnuovo, Jacob Wasswa, Maria Sarah Nabaggala, Elly Katabira, Mohammed Lamorde, Rachel Lisa King

Abstract

Background: Adherence to treatment is critical for successful treatment outcomes. Although factors influencing antiretroviral therapy (ART) adherence vary, young adults are less likely to adhere owing to psychosocial issues such as stigma, ART-related side effects, and a lack of access to treatment. The Call for Life Uganda (CFLU) mobile health (mHealth) tool is a mobile phone-based technology that provides text messages or interactive voice response functionalities through a web interface and offers 4 modules of support.

Objective: This study aims to describe the acceptability and feasibility of a mobile phone support tool to promote adherence to ART among young adults in a randomized controlled trial.

Methods: An exploratory qualitative design with a phenomenological approach at 2 study sites was used. A total of 17 purposively selected young adults with HIV infection who had used the mHealth tool CFLU from 2 clinics were included. In total, 11 in-depth interviews and 1 focus group discussion were conducted to examine the following topics: experience with the CFLU tool (benefits and challenges), components of the tool, the efficiency of the system (level of comfort, ease, or difficulty in using the system), how CFLU resolved adherence challenges, and suggestions to improve CFLU. Participants belonged to 4 categories of interest: young adults on ART for the prevention of mother-to-child transmission, young adults switching to or on the second-line ART, positive partners in an HIV-discordant relationship, and young adults initiating the first-line ART. All young adults had 12 months of daily experience using the tool. Data were analyzed using NVivo version 11 software (QSR International Limited) based on a thematic approach.

Results: The CFLU mHealth tool was perceived as an acceptable intervention; young adults reported improvement in medication adherence, strengthened clinician-patient relationships, and increased health knowledge from health tips. Appointment reminders and symptom reporting were singled out as beneficial and helped to address the problems of forgetfulness and stigma-related issues. HIV-related stigma was reported by a few young people. Participants requested extra support for scaling up CFLU to make it more youth friendly. Improving the tool to reduce technical issues, including network outages and a period of software failure, was suggested. They suggested that in addition to digital solutions, other support, including the promotion of peer support meetings and the establishment of a designated space and staff members for youth, was also important.

Conclusions: This mHealth tool was an acceptable and feasible strategy for improving ART adherence and retention among young adults in resource-limited settings.

Trial registration: ClinicalTrials.gov NCT02953080; https://ichgcp.net/clinical-trials-registry/NCT02953080.

Keywords: HIV; Uganda; adherence; mHealth; qualitative; young adults.

Conflict of interest statement

Conflicts of Interest: RPR discloses that Infectious Diseases Institute receives research funding from Janssen, the Pharmaceutical Companies of Johnson and Johnson for work on Call for Life and other research projects.

©Adelline Twimukye, Agnes Bwanika Naggirinya, Rosalind Parkes-Ratanshi, Ronnie Kasirye, Agnes Kiragga, Barbara Castelnuovo, Jacob Wasswa, Maria Sarah Nabaggala, Elly Katabira, Mohammed Lamorde, Rachel Lisa King. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 14.06.2021.

References

    1. UNAIDS data 2019. UN Joint Programme on HIV/AIDS (UNAIDS) 2019. [2019-12-15]. .
    1. 2018 Statistical Abstract. Uganda Bureau of Statistics. 2018. [2019-12-10]. .
    1. Uganda Demographic and Health Survey. Uganda Bureau of statistics. 2016. [2019-12-02]. .
    1. Uganda population-based HIV impact assessment (UPHIA) 2016-2017. Ministry of Health, Uganda. 2019. Jul, [2019-12-16]. .
    1. Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007 Apr 17;146(8):564–73. doi: 10.7326/0003-4819-146-8-200704170-00007.
    1. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003 Oct 15;37(8):1112–8. doi: 10.1086/378301.
    1. Harrigan P, Hogg R, Dong W, Yip B, Wynhoven B, Woodward J, Brumme C, Brumme Z, Mo T, Alexander C, Montaner J. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005 Feb 01;191(3):339–47. doi: 10.1086/427192.
    1. Nachega J, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006 Sep;43(1):78–84. doi: 10.1097/01.qai.0000225015.43266.46.
    1. Whiteley L, Brown L, Lally M, Heck N, van den Berg JJ. A mobile gaming intervention to increase adherence to antiretroviral treatment for youth living with HIV: development guided by the information, motivation, and behavioral skills model. JMIR Mhealth Uhealth. 2018 Apr 23;6(4):e96. doi: 10.2196/mhealth.8155.
    1. Naomi W. Determinants of adherence to antiretroviral among HIV positive adolescents at comprehensive care clinic, Gertrude's Children Hospital, Nairobi, Kenya. Am J Nurs Sci. 2018;7(1):23. doi: 10.11648/j.ajns.20180701.13.
    1. Becker SL, Dezii CM, Burtcel B, Kawabata H, Hodder S. Young HIV-infected adults are at greater risk for medication nonadherence. MedGenMed. 2002 Jul 30;4(3):21.
    1. Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2012;2012:574656. doi: 10.1155/2012/574656. doi: 10.1155/2012/574656.
    1. The Uganda National Household Survey 2016/2017. Uganda Bureau of Statistics (UBOS) 2018. [2019-12-06]. .
    1. Mitchell KJ, Bull S, Kiwanuka J, Ybarra ML. Cell phone usage among adolescents in Uganda: acceptability for relaying health information. Health Educ Res. 2011 Oct;26(5):770–81. doi: 10.1093/her/cyr022.
    1. Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, Namagala E, Ikoona E. Using mobile phones to improve clinic attendance amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and prospective study. AIDS Behav. 2010 Dec;14(6):1347–52. doi: 10.1007/s10461-010-9780-2.
    1. Rana Y, Haberer J, Huang H, Kambugu A, Mukasa B, Thirumurthy H, Wabukala P, Wagner GJ, Linnemayr S. Short message service (SMS)-based intervention to improve treatment adherence among HIV-positive youth in Uganda: focus group findings. PLoS One. 2015;10(4):e0125187. doi: 10.1371/journal.pone.0125187.
    1. Ammassari A, Trotta MP, Shalev N, Tettoni MC, Maschi S, Di Sora F, Orofino G, d'Ettorre G, Bai F, Celesia MB, Roldan EQ, Maserati R, Sterrantino G, Tommasi C, Boumis E, Iardino MR, Antinori A. Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2011 Dec 01;58(4):e113–5. doi: 10.1097/QAI.0b013e3182359d2a.
    1. Mbuagbaw L, Mursleen S, Lytvyn L, Smieja M, Dolovich L, Thabane L. Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer. BMC Health Serv Res. 2015 Jan 22;15:33. doi: 10.1186/s12913-014-0654-6.
    1. Lester R, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010 Nov 27;376(9755):1838–45. doi: 10.1016/S0140-6736(10)61997-6.
    1. Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 May 15;30(8):1295–300. doi: 10.1097/QAD.0000000000001021.
    1. Sidney K, Antony J, Rodrigues R, Arumugam K, Krishnamurthy S, D'souza G, De Costa A, Shet A. Supporting patient adherence to antiretrovirals using mobile phone reminders: patient responses from South India. AIDS Care. 2012;24(5):612–7. doi: 10.1080/09540121.2011.630357.
    1. Mack N, Woodsong C, MacQueen KM, Guest G, Namey E. Qualitative Research Methods: A Data Collector's Field Guide. Research Triangle Park, North Carolina 27709, USA: Family Health International; 2005. Focus groups; pp. 51–82.
    1. Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D. A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS Behav. 2016 May;20(5):1049–59. doi: 10.1007/s10461-015-1192-x.
    1. MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013 Jan;17(1):86–93. doi: 10.1007/s10461-012-0364-1.
    1. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR, Adolescent Medicine HIV/AIDS Research Network Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003 Mar;157(3):249–55. doi: 10.1001/archpedi.157.3.249.
    1. Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J, Musinguzi J, Wanyenze RK. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017 Mar 21;17(1):94. doi: 10.1186/s12884-017-1276-x.
    1. Ali EE, Chew L, Yap KY. Evolution and current status of mhealth research: a systematic review. BMJ Innov. 2016 Jan 05;2(1):33–40. doi: 10.1136/bmjinnov-2015-000096.
    1. Watkins JA, Goudge J, Gómez-Olivé FX, Huxley C, Dodd K, Griffiths F. mHealth text and voice communication for monitoring people with chronic diseases in low-resource settings: a realist review. BMJ Glob Health. 2018;3(2):e000543. doi: 10.1136/bmjgh-2017-000543.
    1. Watkins JO, Goudge J, Gómez-Olivé FX, Griffiths F. Mobile phone use among patients and health workers to enhance primary healthcare: a qualitative study in rural South Africa. Soc Sci Med. 2018 Feb;198:139–47. doi: 10.1016/j.socscimed.2018.01.011.
    1. Siedner MJ, Santorino D, Haberer JE, Bangsberg DR. Know your audience: predictors of success for a patient-centered texting app to augment linkage to HIV care in rural Uganda. J Med Internet Res. 2015 Mar 24;17(3):e78. doi: 10.2196/jmir.3859.
    1. Lund S, Hemed M, Nielsen BB, Said A, Said K, Makungu MH, Rasch V. Mobile phones as a health communication tool to improve skilled attendance at delivery in Zanzibar: a cluster-randomised controlled trial. Br J Obstet Gynaecol. 2012 Sep;119(10):1256–64. doi: 10.1111/j.1471-0528.2012.03413.x.
    1. Crawford J, Larsen-Cooper E, Jezman Z, Cunningham SC, Bancroft E. SMS versus voice messaging to deliver MNCH communication in rural Malawi: assessment of delivery success and user experience. Glob Health Sci Pract. 2014 Feb;2(1):35–46. doi: 10.9745/GHSP-D-13-00155.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner